Paying user area
Try for free
Abiomed Inc. pages available for free this week:
- Cash Flow Statement
- Common-Size Balance Sheet: Assets
- Analysis of Liquidity Ratios
- Analysis of Solvency Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value to EBITDA (EV/EBITDA)
- Enterprise Value to FCFF (EV/FCFF)
- Price to Book Value (P/BV) since 2005
- Analysis of Revenues
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abiomed Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Inventory Disclosure
Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Raw materials and supplies | |||||||||||||
Work-in-progress | |||||||||||||
Finished goods | |||||||||||||
Inventories, net |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
- Inventories Trend Analysis
- There is a clear upward trend in total inventories, with the value increasing from 34,931 thousand US dollars in 2017 to 93,981 thousand US dollars in 2022. This represents a nearly threefold increase over the six-year period, indicating a substantial accumulation of inventory assets.
- Raw Materials and Supplies
- Raw materials and supplies exhibit steady growth from 9,784 thousand US dollars in 2017, peaking at 31,411 thousand US dollars in 2020. Subsequently, the value slightly declines to 27,782 thousand US dollars in 2021 before a modest increase to 28,326 thousand US dollars in 2022. This pattern suggests a buildup until 2020 followed by a stabilization in raw material holdings.
- Work-in-Progress (WIP)
- The work-in-progress inventory sees consistent growth from 16,504 thousand US dollars in 2017 to a peak of 35,195 thousand US dollars in 2019, after which it remains relatively stable around 35,000 thousand US dollars through 2022. The plateau after 2019 indicates a steady level of production activity or balanced conversion of WIP to finished goods.
- Finished Goods
- Finished goods inventory increases from 8,643 thousand US dollars in 2017 to 23,669 thousand US dollars in 2020, reflecting increased production or accumulation. However, the value drops significantly to 18,090 thousand US dollars in 2021 before rising again sharply to 30,867 thousand US dollars in 2022. This fluctuation could indicate variable sales performance or strategic stockpiling in response to market demand changes.
- Overall Observations
- The combined inventory growth suggests strategic accumulation or increased production capacity over time. The stabilization of work-in-progress indicates efficiency in production cycles post-2019, while fluctuations in finished goods hint at variable demand or inventory management adjustments. The slight reduction in raw materials after 2020 may reflect procurement optimization or supply chain factors.